ERAPs (ERAP1 and ERAP2) are emerging therapeutic targets associated with multiple autoimmune diseases. Genomics will assemble the largest available genetic resource to evaluate how ERAP variants influence an individual’s risk of developing multiple autoimmune diseases. Insights will be used to strengthen Greywolf Therapeutics’ autoimmune disease pipeline. Oxford, England — Genomics, a science-led techbio company using large-scale […]
Authorization expands academic and industry researcher access for LNP delivery optimization, mRNA vaccine development and gene therapy research MADISON, Wis. — A new agreement between Promega Corporation and the RNA & Formulation Core at the University of British Columbia will enable the facility to manufacture and distribute mRNA constructs incorporating the sequence encoding NanoLuc® luciferase. This will facilitate researchers […]
Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery Integrated solutions: Seamless integration of EDGE-developed quantitative assays with scalable hardware and AI-driven analytics from ZEISS to redefine bioimaging in biopharma Strategic focus: Enabling automation and enhancing decision-making through quantitative imaging, establishing an AI-native data foundation accelerating GenAI adoption Customer impact: Standardized […]
Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making RESEARCH TRIANGLE PARK, N.C.–Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a funded research collaboration […]
Expands access to streamlined genomic data analysis across the PacBio partner ecosystem MENLO PARK, Calif. & BERLIN — PacBio (NASDAQ: PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for clinical and research genomics, today announced that Lucid Genomics has joined the PacBio Compatible partner program as […]
Membership deepens ENPICOM’s commitment to advance AI and autonomous agent infrastructure for life sciences R&D ‘s-Hertogenbosch, The Netherlands – Life Science Newswire – ENPICOM, an innovative bioinformatics and AI company, today announced that it has joined the Pistoia Alliance, the global not-for-profit organization working to lower barriers to innovation in life science and healthcare R&D. […]
Claret Bioscience and New England Biolabs (NEB® ) have entered into a co-promotion agreement to support researchers using SRSLY® MethylPlus in combination with the NEBNext® EM-seq™ v2 Conversion Module. SRSLY MethylPlus and SRSLY Uracil+ products are designed to integrate with enzymatic methyl-conversion workflows, enabling high-quality library preparation for methylation profiling and fragmentomics research. The collaboration […]
Saint Germain-en-Laye, France, San José, USA, and Helsinki, Finland – Life Science Newswire – Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput antimicrobial resistance (AMR) surveillance from environmental samples. This collaboration unites Takara Bio’s scalable instrumentation with Resistomap’s environmental AMR intelligence to address […]
Partnership highlights streamlined spatial biology workflows combining advanced multiplex IF reagents and AI-powered image analysis OBERKOCHEN, Germany — Revolune GmbH, a life science company focused on simplifying spatial biology through streamlined multiplex immunofluorescence (mIF) reagents, today announced it will exhibit at the American Association for Cancer Research (AACR) Annual Meeting 2026 together with MindPeak, a leader in AI-powered pathology analysis. […]
Nanion Technologies GmbH Munich, Germany Following several years of close collaboration, Nanion Technologies and Elements are proud to announce the successful integration of Elements’ cutting-edge microchip-based amplifier technology into Nanion’s newly launched Patchlinere and Patchlinerm platforms. Driving innovation in electrophysiology Nanion has long been committed to advancing automated patch clamp technologies to accelerate drug discovery […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
